Edition:
United States

McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

152.65USD
23 Feb 2018
Change (% chg)

$2.56 (+1.71%)
Prev Close
$150.09
Open
$150.72
Day's High
$153.05
Day's Low
$150.37
Volume
294,505
Avg. Vol
545,295
52-wk High
$178.86
52-wk Low
$133.90

Latest Key Developments (Source: Significant Developments)

McKesson Reports Q3 Adjusted Earnings Per Share $3.41
Thursday, 1 Feb 2018 07:00am EST 

Feb 1 (Reuters) - McKesson Corp ::MCKESSON REPORTS FISCAL 2018 THIRD-QUARTER RESULTS.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $12.50 TO $12.80.Q3 ADJUSTED EARNINGS PER SHARE $3.41.Q3 GAAP EARNINGS PER SHARE $4.32 FROM CONTINUING OPERATIONS.Q3 REVENUE $53.6 BILLION VERSUS I/B/E/S VIEW $52.03 BILLION.SEES FY 2018 GAAP EARNINGS PER SHARE $7.65 TO $9.00 FROM CONTINUING OPERATIONS.Q3 EARNINGS PER SHARE VIEW $2.93 -- THOMSON REUTERS I/B/E/S.MCKESSON - QTRLY EARNINGS PER SHARE INCLUDED A NET TAX BENEFIT OF APPROXIMATELY $370 MILLION, OR $1.78, RELATED TO TAX CUTS AND JOBS ACT OF 2017.MCKESSON - RAISING AND NARROWING FISCAL 2018 ADJUSTED EARNINGS PER SHARE OUTLOOK FROM A RANGE OF $11.80 TO $12.50 TO NEW RANGE OF $12.50 TO $12.80.FY2018 EARNINGS PER SHARE VIEW $12.25 -- THOMSON REUTERS I/B/E/S.  Full Article

Atlassian Appoints James Beer As CFO
Monday, 18 Dec 2017 09:10am EST 

Dec 18 (Reuters) - Atlassian Corp Plc ::ATLASSIAN APPOINTS JAMES BEER AS CHIEF FINANCIAL OFFICER.ATLASSIAN CORP PLC - ‍ JAMES BEER WILL START AT ATLASSIAN ON FEBRUARY 20, 2018​.ATLASSIAN CORP PLC - ATLASSIAN'S CURRENT CFO MURRAY DEMO WILL LEAVE CO AT END OF JAN 2018.  Full Article

Mckesson Announces Departure Of James Beer, EVP And CFO
Monday, 18 Dec 2017 09:00am EST 

Dec 18 (Reuters) - Mckesson Corp ::MCKESSON ANNOUNCES DEPARTURE OF JAMES BEER, EVP AND CFO; APPOINTS INTERNAL SUCCESSOR, BRITT VITALONE; REAFFIRMS FISCAL 2018 OUTLOOK.REAFFIRMS FY 2018 ADJUSTED EARNINGS PER SHARE VIEW $11.80 TO $12.50.- ‍ BRITT VITALONE, WILL BE APPOINTED EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER OF MCKESSON, EFFECTIVE JANUARY 1, 2018​.- ‍ BEER WILL JOIN ATLASSIAN, AN ENTERPRISE COLLABORATION COMPANY, IN SAN FRANCISCO, AS CHIEF FINANCIAL OFFICER, EFFECTIVE FEBRUARY 2018​.FY2018 EARNINGS PER SHARE VIEW $12.18 -- THOMSON REUTERS I/B/E/S.  Full Article

Mckesson Medical-Surgical Says Signed Exclusive Agreement With Biomérieux To Serve U.S. Community Hospital Market​
Thursday, 14 Dec 2017 08:00am EST 

Dec 14 (Reuters) - Mckesson Corp ::MCKESSON MEDICAL-SURGICAL SAYS SIGNED EXCLUSIVE AGREEMENT WITH BIOMÉRIEUX INC TO SERVE U.S. COMMUNITY HOSPITAL MARKET​.MCKESSON MEDICAL-SURGICAL INC SAYS CERTAIN BIOMÉRIEUX PRODUCTS AND REAGENTS WILL NOW BE AVAILABLE THROUGH MCKESSON.  Full Article

Mckesson acquires RxCrossroads in a deal valued at $735 mln
Monday, 6 Nov 2017 04:16pm EST 

Nov 6 (Reuters) - Mckesson Corp ::Mckesson strengthens its portfolio of manufacturer solutions with the acquisition of RxCrossroads.Mckesson Corp - ‍transaction is valued at $735 million, or approximately $635 million net of present value of incremental cash tax benefits​.Mckesson Corp - ‍transaction will be funded by cash on hand​.Mckesson - ‍signed agreement to buy RxCrossroads from Cvs Health Corporation​.Mckesson Corp - ‍co expects impact of deal to be about 20 cents accretive to adjusted earnings per diluted share by third year following close of deal​.  Full Article

MCKESSON SIGNS AGREEMENT WITH NRG TO INSTALL SOLAR ARRAYS AT MCKESSON FACILITY
Monday, 30 Oct 2017 08:30am EDT 

Oct 30 (Reuters) - Mckesson ::MCKESSON SIGNS AGREEMENT WITH NRG TO INSTALL SOLAR ARRAYS AT MCKESSON FACILITY.‍AS PART OF SOLAR POWER PURCHASE AGREEMENT, SOLAR ARRAYS WILL BE INSTALLED AT MCKESSON DISTRIBUTION CENTER IN ROBBINSVILLE, NEW JERSEY​.ENTERED LONG-TERM AGREEMENT WITH NRG TO PURCHASE SOLAR POWER FROM SOLAR ARRAYS THAT NRG WILL INSTALL AT A MAJOR MCKESSON FACILITY​.‍NRG WILL WORK WITH CO TO DELIVER PROJECT FROM INITIAL PLANNING TO FINAL INSTALLATION, WHICH IS ESTIMATED TO BE FULLY OPERATIONAL IN 2018​.  Full Article

McKesson reports Q2 adjusted earnings per share $3.28
Thursday, 26 Oct 2017 07:00am EDT 

Oct 26 (Reuters) - McKesson Corp :McKesson reports fiscal 2018 second-quarter results.Sees FY 2018 adjusted earnings per share $11.80 to $12.50.Q2 adjusted earnings per share $3.28.Q2 GAAP earnings per share $0.01 from continuing operations.Q2 revenue $52.1 billion versus I/B/E/S view $51.73 billion.Sees FY 2018 GAAP earnings per share $4.80 to $6.90 from continuing operations.Q2 earnings per share view $2.80 -- Thomson Reuters I/B/E/S.McKesson Corp - ‍Paul Julian, executive vice president and group president, distribution solutions, will retire at close of calendar year​.McKesson Corp - ‍Q2 earnings per share included $2.41 of non-cash goodwill and other long-lived asset impairment charges and $0.19 of restructuring charges​.FY2018 earnings per share view $12.05 -- Thomson Reuters I/B/E/S.  Full Article

‍BIOLOGICS SAYS SELECTED BY ELI LILLY TO BE IN LIMITED DISTRIBUTION NETWORK FOR VERZENIO​
Wednesday, 11 Oct 2017 11:21am EDT 

Oct 11 (Reuters) - Biologics Inc::‍BIOLOGICS INC SAYS HAS BEEN SELECTED BY ELI LILLY AND COMPANY TO BE IN LIMITED DISTRIBUTION NETWORK FOR VERZENIO​.  Full Article

Allscripts to acquire Mckesson’s Enterprise Information Solutions business
Thursday, 3 Aug 2017 04:01pm EDT 

Aug 3 (Reuters) - Allscripts Healthcare Solutions Inc :Allscripts to acquire Mckesson’s enterprise information solutions business.Allscripts to acquire Mckesson’s Enterprise Information Solutions business.Allscripts Healthcare Solutions Inc - deal for ‍$185 million​.Allscripts Healthcare Solutions Inc - ‍Allscripts intends to fund purchase price through its existing secured credit facilities and cash balances​.Allscripts Healthcare Solutions Inc - ‍definitive agreement to acquire Mckesson Corporation's hospital and health system IT business​.  Full Article

McKesson says continues to see competitive market for selling generic pharmaceuticals in the U.S.
Thursday, 27 Jul 2017 09:41am EDT 

July 27 (Reuters) - Mckesson :Says entered year with assumption of branded inflation in mid-single digits, and q1 experience was slightly ahead of the assumption - conf call.Says continue to see competitive market for selling generic pharmaceuticals in the u.s., but with less pricing variability- conf call.Says expect to lap the independent pharmacy sell-side pricing impact by the end of our fiscal 2018 second quarter - conf call.Says comfortable with fiscal '18 assumption; reiterates results will be more heavily weighted to second half of fiscal year - conf call.Says "seeing a litlte bit less of a frequency" with regards to branded manufacturer pricing environment - conf call.  Full Article

BRIEF-McKesson Corp Files Preliminary Prospectus Supplement Related To A Potential Two-Part Note Offering

* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL TWO-PART NOTE OFFERING OF UP TO EUR 750 MILLION - SEC FILING Source text : (http://bit.ly/2H0ogwC) Further company coverage: